Home » OxThera Secures $10M Investment to Continue Clinical Programs
OxThera Secures $10M Investment to Continue Clinical Programs
Swedish biopharmaceutical firm OxThera has received $10 million from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May